Autologous hematopoietic transplantation following COVID‐19 infection
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981617/
Marthilde Brzycki, 1 Robert Richard, 1 , 2 Nicholas Burwick, 1 , 2 Solomon Graf, 1 , 3 , 4 Craig O'Brien, 1 Daniel Wu, 1 , 3 and Thomas R. Chauncey 1 , 3 , 4 Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma ( N Engl J Med 2017, 376; 1311).
-
Mark FeslerApril 10, 2021An interesting report. More knowledge in this area is needed as clinicians presently face challenging decisions on balancing risks of malignancy and covid without a solid evidence base